245 related articles for article (PubMed ID: 33622899)
21. Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004).
Altin D; Taskin S; Tokgozoglu N; Vatansever D; Guler AH; Gungor M; Tasci T; Turan H; Kahramanoglu I; Yalcin I; Celik C; Kose F; Ortac F; Arvas M; Ayhan A; Taskiran C
J Surg Oncol; 2021 Feb; 123(2):638-645. PubMed ID: 33259650
[TBL] [Abstract][Full Text] [Related]
22. Sentinel Lymph Node Biopsy in the Treatment of Endometrial Cancer: Why We Fail? Results of a Prospective Multicenter Study on the Factors Associated with Failure of Node Mapping with Indocyanine Green.
Ianieri MM; Puppo A; Novelli A; Campolo F; Staniscia T; Di Martino G; Piovano E; Bruni F; Roviglione G; Mautone D; Ceccaroni M
Gynecol Obstet Invest; 2019; 84(4):383-389. PubMed ID: 30661071
[TBL] [Abstract][Full Text] [Related]
23. Comparing carbon nanoparticles and indocyanine green for sentinel lymph node mapping in endometrial cancer: A randomized-controlled single-center trial.
He M; Liang S; Deng H; Zhang G; Wang Z; Yang X; Wang Y; Li Y; Sun X; Wang J
J Surg Oncol; 2023 Aug; 128(2):332-343. PubMed ID: 37027324
[TBL] [Abstract][Full Text] [Related]
24. Comparison of outcomes between the one-step and two-step sentinel lymph node mapping techniques in endometrial cancer.
Kim YN; Eoh KJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
Int J Gynecol Cancer; 2020 Mar; 30(3):318-324. PubMed ID: 31992601
[TBL] [Abstract][Full Text] [Related]
25. Association between sentinel lymph node biopsy and micrometastasis in endometrial cancer.
Matsuo K; Klar M; Khetan VU; Violette CJ; Youssefzadeh AC; Yessaian AA; Roman LD
Eur J Obstet Gynecol Reprod Biol; 2022 Aug; 275():91-96. PubMed ID: 35763967
[TBL] [Abstract][Full Text] [Related]
26. Adipose-only sentinel lymph nodes: a finding during the adaptation of a sentinel lymph node mapping algorithm with indocyanine green in women with endometrial cancer.
Harold JA; Uyar D; Rader JS; Bishop E; Nugent M; Simpson P; Bradley WH
Int J Gynecol Cancer; 2019 Jan; 29(1):53-59. PubMed ID: 30640684
[TBL] [Abstract][Full Text] [Related]
27. FIGO stage IIIC endometrial cancer identification among patients with complex atypical hyperplasia, grade 1 and 2 endometrioid endometrial cancer: laparoscopic indocyanine green sentinel lymph node mapping versus frozen section of the uterus, why get around the problem?
Papadia A; Gasparri ML; Siegenthaler F; Imboden S; Mohr S; Mueller MD
J Cancer Res Clin Oncol; 2017 Mar; 143(3):491-497. PubMed ID: 27834005
[TBL] [Abstract][Full Text] [Related]
28. Laparoscopic sentinel lymph node mapping with indocyanine green in endometrial cancer: surgeon's learning curve (cumulative sum analysis).
Gedgaudaite M; Paskauskas S; Bartusevicius A; Celiesiute J; Svedas E; Vaitkiene D; Drejeriene E; Inciura A; Gaurilcikas A
Int J Gynecol Cancer; 2023 Apr; 33(4):521-527. PubMed ID: 36787934
[TBL] [Abstract][Full Text] [Related]
29. Sentinel Node Mapping Using Indocyanine Green and Near-infrared Fluorescence Imaging Technology for Uterine Malignancies: Preliminary Experience With the Da Vinci Xi System.
Siesto G; Romano F; Fiamengo B; Vitobello D
J Minim Invasive Gynecol; 2016; 23(4):470-1. PubMed ID: 26767824
[TBL] [Abstract][Full Text] [Related]
30. Technetium-99m-indocyanine green versus technetium-99m-methylene blue for sentinel lymph node biopsy in early-stage endometrial cancer.
Cabrera S; Bebia V; Franco-Camps S; Forcada C; Villasboas-Rosciolesi D; Navales I; Pérez-Benavente A; Gil-Moreno A
Int J Gynecol Cancer; 2020 Mar; 30(3):311-317. PubMed ID: 31992599
[TBL] [Abstract][Full Text] [Related]
31. Utility of indocyanine green as a single tracer for sentinel node biopsy in endometrial cancer.
Cabezas Palacios MN; García Pineda V; Gracia Segovia M; Diestro Tejeda MD; Hernández Gutiérrez A; Zapardiel Gutiérrez I
J Obstet Gynaecol Res; 2022 Jan; 48(1):222-229. PubMed ID: 34698419
[TBL] [Abstract][Full Text] [Related]
32. A Prospective Cohort Study Comparing Colorimetric and Fluorescent Imaging for Sentinel Lymph Node Mapping in Endometrial Cancer.
Holloway RW; Ahmad S; Kendrick JE; Bigsby GE; Brudie LA; Ghurani GB; Stavitzski NM; Gise JL; Ingersoll SB; Pepe JW
Ann Surg Oncol; 2017 Jul; 24(7):1972-1979. PubMed ID: 28265777
[TBL] [Abstract][Full Text] [Related]
33. The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer.
Kim JH; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
World J Surg Oncol; 2018 Mar; 16(1):52. PubMed ID: 29523141
[TBL] [Abstract][Full Text] [Related]
34. Predictive factors of sentinel lymph node failed mapping in endometrial carcinoma patients: a systematic review and meta-analysis.
Raffone A; Fanfani F; Raimondo D; Rovero G; Renzulli F; Travaglino A; De Laurentiis U; Santoro A; Zannoni GF; Casadio P; Scambia G; Seracchioli R; Mollo A
Int J Gynecol Cancer; 2023 Jun; 33(6):853-859. PubMed ID: 36914172
[TBL] [Abstract][Full Text] [Related]
35. Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis.
Bodurtha Smith AJ; Fader AN; Tanner EJ
Am J Obstet Gynecol; 2017 May; 216(5):459-476.e10. PubMed ID: 27871836
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of sentinel lymph node mapping using indocyanine green and fluorescent imaging in the diagnosis of lymph node metastasis in endometrial cancer.
Lee GW; Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
J Obstet Gynaecol; 2021 May; 41(4):605-611. PubMed ID: 32815448
[TBL] [Abstract][Full Text] [Related]
37. Maximizing sentinel node detection in endometrial cancer with dual cervical and transcervical fundal indocyanine green injection: 5-year single-center prospective study.
Ruiz R; Gorostidi M; Jaunarena I; Cobas P; Lekuona A
Eur J Obstet Gynecol Reprod Biol; 2021 Jun; 261():59-64. PubMed ID: 33892210
[TBL] [Abstract][Full Text] [Related]
38. Pelvic sentinel lymph node biopsy in endometrial cancer-a simplified algorithm based on histology and lymphatic anatomy.
Bollino M; Geppert B; Lönnerfors C; Falconer H; Salehi S; Persson J
Int J Gynecol Cancer; 2020 Mar; 30(3):339-345. PubMed ID: 32075897
[TBL] [Abstract][Full Text] [Related]
39. Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99
Papadia A; Zapardiel I; Bussi B; Ghezzi F; Ceccaroni M; De Ponti E; Elisei F; Imboden S; de la Noval BD; Gasparri ML; Di Martino G; De Santiago J; Mueller M; Vecchione F; Dell'Orto F; Buda A
J Cancer Res Clin Oncol; 2017 Mar; 143(3):475-480. PubMed ID: 27812854
[TBL] [Abstract][Full Text] [Related]
40. The safety and feasibility of minimally invasive sentinel lymph node staging using indocyanine green in the management of endometrial cancer.
Mendivil AA; Abaid LN; Brown JV; Mori KM; Beck TL; Epstein HD; Micha JP; Goldstein BH
Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():29-32. PubMed ID: 29529474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
